COSMO Pharmaceuticals SA (0RGI) — Working Capital to Net Assets Ratio
COSMO Pharmaceuticals SA (0RGI) has a Working Capital to Net Assets ratio of 29.7% as of June 2025. Working capital of £138.51 Million (current assets of £187.23 Million minus current liabilities of £48.72 Million) is measured against net assets of £466.98 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See 0RGI equity to assets ratio to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
COSMO Pharmaceuticals SA Working Capital to Net Assets (2004–2024)
This chart shows how COSMO Pharmaceuticals SA's Working Capital to Net Assets ratio has evolved across 21 annual periods from 2004 to 2024. As of June 2025, the ratio stands at 29.7%, reflecting working capital of £138.51 Million against net assets of £466.98 Million GBP. Check 0RGI intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for COSMO Pharmaceuticals SA (2004–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for COSMO Pharmaceuticals SA from 2004 to 2024, covering 21 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see 0RGI market cap overview.
| Year | WC/NA Ratio | Working Capital (GBP) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 30.5% | £153.99 Million | £505.09 Million | £202.26 Million | £48.27 Million | ▲ +12.7 pp |
| 2023 | 17.8% | £76.51 Million | £429.04 Million | £102.23 Million | £25.71 Million | ▼ -6.1 pp |
| 2022 | 24.0% | £111.15 Million | £463.79 Million | £306.10 Million | £194.95 Million | ▼ -25.7 pp |
| 2021 | 49.7% | £254.61 Million | £512.68 Million | £275.85 Million | £21.24 Million | ▼ -8.1 pp |
| 2020 | 57.8% | £231.07 Million | £400.12 Million | £252.87 Million | £21.79 Million | ▼ -15.1 pp |
| 2019 | 72.8% | £286.66 Million | £393.73 Million | £302.37 Million | £15.71 Million | ▼ -7.9 pp |
| 2018 | 80.7% | £358.82 Million | £444.85 Million | £374.17 Million | £15.35 Million | ▲ +42.8 pp |
| 2017 | 37.8% | £177.87 Million | £470.12 Million | £197.31 Million | £19.43 Million | ▼ -2.7 pp |
| 2016 | 40.5% | £168.36 Million | £415.56 Million | £187.07 Million | £18.72 Million | ▲ +12.5 pp |
| 2015 | 28.0% | £112.89 Million | £403.65 Million | £137.93 Million | £25.04 Million | ▲ +21.4 pp |
| 2014 | 6.6% | £10.05 Million | £152.29 Million | £70.71 Million | £60.66 Million | ▼ -74.5 pp |
| 2013 | 81.1% | £178.63 Million | £220.16 Million | £188.33 Million | £9.70 Million | ▲ +59.0 pp |
| 2012 | 22.2% | £27.60 Million | £124.60 Million | £39.98 Million | £12.38 Million | ▼ -6.7 pp |
| 2011 | 28.8% | £18.29 Million | £63.43 Million | £28.60 Million | £10.31 Million | ▲ +1.0 pp |
| 2010 | 27.8% | £16.23 Million | £58.37 Million | £43.44 Million | £27.21 Million | ▼ -9.9 pp |
| 2009 | 37.7% | £22.54 Million | £59.80 Million | £29.83 Million | £7.29 Million | ▼ -18.5 pp |
| 2008 | 56.2% | £24.31 Million | £43.24 Million | £33.69 Million | £9.38 Million | ▼ -20.8 pp |
| 2007 | 77.1% | £27.09 Million | £35.15 Million | £33.67 Million | £6.58 Million | ▲ +106.5 pp |
| 2006 | -29.5% | £-1.57 Million | £5.34 Million | £9.98 Million | £11.56 Million | ▲ +579.4 pp |
| 2005 | -608.9% | £-3.84 Million | £631.00K | £8.30 Million | £12.15 Million | ▼ -1018.6 pp |
| 2004 | 409.8% | £-3.61 Million | £-880.00K | £4.14 Million | £7.75 Million | — |